Joseph Zakrzewski Net Worth & Insider Trades
Joseph Zakrzewski - Director, Sangamo Therapeutics, Inc
What is Joseph Zakrzewski's Net Worth?
The current estimated net worth of Sangamo Therapeutics, Inc's Director, Joseph Zakrzewski, is estimated to be about $61.86M . Joseph Zakrzewski owns about 30,000 units of Sangamo Therapeutics, Inc common stock. In the last 3 years at Sangamo Therapeutics, Inc, Joseph Zakrzewski has sold an estimated value of $0 worth.
What is Joseph Zakrzewski's Past Insider Trading?
Joseph Zakrzewski's largest purchase order was 20,000 units , worth over $123K on March 13, 2020. In total, Joseph Zakrzewski has made about 4 transactions over 3 years of their time at Sangamo Therapeutics, Inc. Joseph Zakrzewski usually trades in June and March, with the busiest year in 2020. The most recent transaction was a purchase order of 5,000 units , worth over $24.95K on March 19, 2020.
Joseph S Zakrzewski
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Joseph Zakrzewski's' Mailing Address?
- Mailing address is 509 Waterview Place New Hope PA 18938 PA
Sangamo Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Alexander D. Macrae | 2020 | $681,797 | - | $1,147,500 | $1,488,746 | $511,348 | $5,639 | $3,835,030 |
| Alexander D. Macrae | 2019 | $661,939 | - | $571,148 | $2,274,230 | $436,880 | $42,358 | $3,986,555 |
| Alexander D. Macrae | 2018 | $636,480 | - | $631,575 | $2,410,657 | $420,077 | $5,639 | $4,104,428 |
| Sung H. Lee | 2020 | $438,262 | - | $340,000 | $443,316 | $215,000 | $5,639 | $1,442,217 |
| Sung H. Lee | 2019 | $72,500 | $200,000 | $452,813 | $1,757,679 | $47,415 | $273 | $2,530,680 |
| Gary H. Loeb | 2020 | $406,000 | - | $340,000 | $441,110 | $200,564 | $5,639 | $1,393,313 |
| Gary H. Loeb | 2019 | $166,667 | - | - | $1,788,475 | $87,200 | $683 | $2,043,025 |
| D. Mark McClung | 2020 | $276,667 | $150,000 | $916,000 | $1,187,220 | $136,245 | $5,093 | $2,671,225 |
| R. Andrew Ramelmeier | 2020 | $416,000 | $50,000 | $374,000 | $485,221 | $203,840 | $5,639 | $1,534,700 |
| R. Andrew Ramelmeier | 2019 | $382,965 | - | $112,875 | $449,453 | $153,608 | $5,639 | $1,104,540 |
| Stéphane Boissel | 2020 | $318,283 | - | $374,000 | $485,221 | - | $256,472 | $1,433,976 |
| Stéphane Boissel | 2019 | $483,600 | - | $158,025 | $629,234 | $212,784 | $1,639 | $1,485,282 |
| Stéphane Boissel | 2018 | $120,390 | $100,000 | - | $2,052,792 | - | $316,884 | $2,590,066 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1001233/000162828021006458/sgmo_proxyx2021xdefxvs.htm
What are Sangamo Therapeutics, Inc's Past Insider Trades?
Sangamo Therapeutics, Inc's most recent insider trade came on August 31, 2022 by Biogen Inc and Biogen Ma Inc who sold 500,000 units worth $2.66M . In the last 19 years, insiders at Sangamo Therapeutics, Inc have sold an estimated value of $143.73M and bought an estimated value of $70.12M worth of shares. Insider trading is most common in June, with the busiest year in 2014. The most active traders at the company are Edward Lanphier II, Director, Philip Gregory, SVP Research & CSO, and Ward Henry Wolff, Exec VP & CFO .
SANGAMO THERAPEUTICS, INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||